EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Skin Improvement in Japanese Patients With Inflammatory Dermatologic Conditions Using the Injectable Hyaluronic Acid VYC ‐12

Chiharu Watanabe

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Chiharu Watanabe. Beteiligte Einrichtung: Chiharu Dermatology Clinic, Saitama, Japan. Hauptthemen laut MEDLINE: Hyaluronic Acid, Rosacea, Acne Vulgaris, Dermatitis, Atopic. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Allergan Aesthetics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many skin disorders of the face have an inflammatory element, including atopic dermatitis, acne vulgaris, and rosacea. VYC‐12 is an injectable hyaluronic acid product with well‐established hydrating effects and potential anti‐inflammatory benefits.

Aims

To assess the utility of VYC‐12 for improving inflammatory skin conditions.

Methods

This was a single‐center, retrospective analysis of adults with a facial inflammatory skin condition that was resistant to standard treatments. A small group was also included who only required treatment for aging‐related concerns. VYC‐12 was injected into the deep dermis based on the standard technique. Imaging was used to assess skin redness and stratum corneum moisture levels. Patient satisfaction was evaluated on a five‐point Likert scale, and adverse events were recorded throughout a mean follow‐up of 4 months.

Results

Fifteen patients were included (86.7% female; mean age: 40.5 ± 9.7 years). Four had atopic dermatitis, 4 had acne vulgaris, and 2 had rosacea; the other 5 had aging‐related dryness and fine lines. Patients received a mean of 3.4 ± 1.2 mL of VYC‐12. Among 10 individuals with an inflammatory skin condition, mean skin redness decreased from 57.7 (arbitrary units) at baseline to 47.9 at 4 months post‐treatment ( p < 0.0005); mean stratum corneum moisture levels increased from 45.1 (arbitrary units) to 75.3 over this period ( p < 0.0005). All 15 subjects were satisfied with the results. There were no adverse events.

Conclusions

VYC‐12 significantly improved skin redness and hydration in patients with inflammatory skin disorders. Further studies are warranted to assess the benefits of combining VYC‐12 with standard treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidRosaceaAcne VulgarisDermatitis, AtopicDermal FillersCosmetic TechniquesHumansFemaleAdultMaleRetrospective StudiesMiddle AgedPatient SatisfactionTreatment OutcomeSkin AgingInjections, IntradermalJapanEast Asian People

Stichwörter der Autor:innen

VYC‐12acne vulgarisatopic dermatitisfine lineshyaluronic acidrosacea

Substanzen

Hyaluronic AcidDermal Fillers

Autor:innen und Institutionen

  • Chiharu Dermatology Clinic, Saitama, Japan.

Förderung

  • Allergan Aesthetics

Zitieren

APA

Watanabe, C. (2025). Skin Improvement in Japanese Patients With Inflammatory Dermatologic Conditions Using the Injectable Hyaluronic Acid VYC ‐12. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70275

Vancouver

Watanabe C. Skin Improvement in Japanese Patients With Inflammatory Dermatologic Conditions Using the Injectable Hyaluronic Acid VYC ‐12. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70275

BibTeX
@article{Watanabe2025,
  author = {Watanabe, Chiharu},
  title = {Skin Improvement in Japanese Patients With Inflammatory Dermatologic Conditions Using the Injectable Hyaluronic Acid VYC ‐12},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70275}
}
Kostenlos starten →